Skip to content

Evaluation of Cardiags Trimod for Analysis of Cardiac Activity

Evaluation of Cardiags Trimod, a New Medical Device for Screening Cardiac Abnormalities

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05162599
Acronym
EVALTRIMOD
Enrollment
120
Registered
2021-12-17
Start date
2022-06-08
Completion date
2023-06-08
Last updated
2024-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Murmur, Heart, Rhythm; Abnormal

Keywords

Medical examination device, Connected cardiac auscultation, Sensors, Heartbeat, Heart sounds, Pulse wave, Electrocardiogram, Pathological heart sounds

Brief summary

The current study concerns Cardiags Trimod, a new non-invasive medical device for cardiac examinations. The evaluation of its effectiveness is done relative to specific standard devices.

Detailed description

Cardiags Trimod, the subject of this study, is a new medical device for rapid and early detection of some of cardiac abnormalities, easy to use by non-cardiologists and portable wherever the patient is. Cardiags Trimod, consisting of a device and software, allows simultaneous recording, visualization and analysis in real time of signals characteristic of cardiac function. It assists healthcare professionals by measuring characteristic time intervals of cardiac function by crossing the various signals, by detecting abnormal rhythms, and murmurs. The study aims to assess the essential requirements : the effectiveness and safety of the device. The study is a research involving the human person.Cardiags Trimod is a medical device with low risk. There is no identified risk for the patient.The patient sample tested consists of sick and healthy individuals. The use of Cardiags Trimod is part of the patient's usual consultation. The identified Gold standards are EKG and echocardiography.

Interventions

DEVICEDiagnostic study, experimental evaluative cross-sectional study

This is a cross-sectional diagnostic study with collection of information from the gold standard (or reference test) and the new device

Sponsors

CARDIAGS
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

This is a cross-sectional diagnostic study with collection of information from the gold standard (or reference tests) and the new device

Eligibility

Sex/Gender
ALL
Age
6 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Persons suitable for receiving an echocardiogram and an electrocardiogram, * People who signed the consent form,

Exclusion criteria

* Protected and vulnerable people, * People refusing to participate in the study,

Design outcomes

Primary

MeasureTime frameDescription
Murmurs detection15 minutesEvaluate the performance of Cardiags Trimod compared to a reference examination, echocardiography, for the detection of murmurs: Presence/Absence
Heart rhythm disorders15 minutesAbnormal and irregular heart rhythm

Secondary

MeasureTime frameDescription
Accuracy of cardiac intervals measures15 minutesMeasures accuracy
Reproductibilty of measurements15 minutesRepetition of three measurements by the same operator
Security and usability1 yearcollection of problems and incidents during clinical study
Acceptability1 yearsatisfaction survey

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026